CHIERIGO, FRANCESCO

CHIERIGO, FRANCESCO  

100010 - Dipartimento di Scienze chirurgiche e diagnostiche integrate  

Mostra records
Risultati 1 - 20 di 27 (tempo di esecuzione: 0.052 secondi).
Titolo Data di pubblicazione Autore(i) File
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 1-gen-2022 Mantica, G.; Suardi, N.; Smelzo, S.; Esperto, F.; Chierigo, F.; Tappero, S.; Borghesi, M.; La Rocca, R.; Oderda, M.; Ennas, M.; Stabile, A.; De Cobelli, F.; Napolitano, L.; Papalia, R.; Gontero, P.; Introini, C.; Briganti, A.; Scarpa, R. M.; Mirone, V.; Montorsi, F.; Gaboardi, F.; Terrone, C.; Cardone, G.
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients 1-gen-2021 Wenzel, M.; Wurnschimmel, C.; Chierigo, F.; Tian, Z.; Shariat, S. F.; Terrone, C.; Saad, F.; Tilki, D.; Graefen, M.; Roos, F. C.; A Kluth, L.; Mandel, P.; Chun, F. K. H.; Karakiewicz, P. I.
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients 1-gen-2022 Hoeh, B.; Hohenhorst, J. L.; Flammia, R.; Horlemann, B.; Sorce, G.; Chierigo, F.; Tian, Z.; Saad, F.; Graefen, M.; Gallucci, M.; Briganti, A.; Terrone, C.; Shariat, S. F.; Kluth, L. A.; Becker, A.; Chun, F. K. H.; Karakiewicz, P. I.
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients 1-gen-2022 Hoeh, B.; Wurnschimmel, C.; Flammia, R. S.; Horlemann, B.; Sorce, G.; Chierigo, F.; Tian, Z.; Saad, F.; Graefen, M.; Gallucci, M.; Briganti, A.; Terrone, C.; Shariat, S. F.; Kluth, L. A.; Mandel, P.; Chun, F. K. H.; Karakiewicz, P. I.
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients 1-gen-2022 Chierigo, F.; Borghesi, M.; Wurnschimmel, C.; Flammia, R. S.; Sorce, G.; Hoeh, B.; Hohenhorst, L.; Tian, Z.; Saad, F.; Tilki, D.; Gallucci, M.; Briganti, A.; Montorsi, F.; Chun, F. K. H.; Shariat, S. F.; Mantica, G.; Suardi, N.; Terrone, C.; Karakiewicz, P. I.
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients 1-gen-2021 Hoeh, B.; Wurnschimmel, C.; Flammia, R. S.; Horlemann, B.; Sorce, G.; Chierigo, F.; Tian, Z.; Saad, F.; Graefen, M.; Gallucci, M.; Briganti, A.; Terrone, C.; Shariat, S. F.; Tilki, D.; Kluth, L. A.; Mandel, P.; Chun, F. K. H.; Karakiewicz, P. I.
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis 1-gen-2022 Chierigo, F.; Wenzel, M.; Wurnschimmel, C.; Flammia, R. S.; Horlemann, B.; Tian, Z.; Saad, F.; Chun, F. K. H.; Tilki, D.; Shariat, S. F.; Gallucci, M.; Borghesi, M.; Suardi, N.; Terrone, C.; Karakiewicz, P. I.
Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes? 1-gen-2022 Mantica, G.; Chierigo, F.; Malinaric, R.; Smelzo, S.; Ambrosini, F.; Beverini, M.; Guano, G.; Caviglia, A.; Rigatti, L.; De Rose, A. F.; Tafuri, A.; De Marchi, D.; Gaboardi, F.; Suardi, N.; Terrone, C.
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity 1-gen-2022 Chierigo, F.; Borghesi, M.; Wurnschimmel, C.; Flammia, R. S.; Horlemann, B.; Sorce, G.; Hoeh, B.; Tian, Z.; Saad, F.; Graefen, M.; Gallucci, M.; Briganti, A.; Montorsi, F.; Chun, F. K. H.; Shariat, S. F.; Mantica, G.; Suardi, N.; Terrone, C.; Karakiewicz, P. I.
Minimally invasive strategies for the treatment of prostate cancer recurrence after radiation therapy: a systematic review 1-gen-2020 Mantica, G.; Chierigo, F.; Suardi, N.; Gomez Rivas, J.; Kasivisvanathan, V.; Papalia, R.; Fiori, C.; Porpiglia, F.; Terrone, C.; Esperto, F.
Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy 1-gen-2021 Wenzel, M.; Wurnschimmel, C.; Chierigo, F.; Flammia, R. S.; Tian, Z.; Shariat, S. F.; Gallucci, M.; Terrone, C.; Saad, F.; Tilki, D.; Graefen, M.; Becker, A.; Kluth, L. A.; Mandel, P.; Chun, F. K. H.; Karakiewicz, P. I.
Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy 1-gen-2021 Wenzel, M.; Wurnschimmel, C.; Chierigo, F.; Tian, Z.; Shariat, S. F.; Terrone, C.; Saad, F.; Tilki, D.; Graefen, M.; Mandel, P.; Kluth, L. A.; Chun, F. K. H.; Karakiewicz, P. I.
Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation Therapy 1-gen-2021 Wenzel, M.; Wurnschimmel, C.; Chierigo, F.; Mori, K.; Tian, Z.; Terrone, C.; Shariat, S. F.; Saad, F.; Tilki, D.; Graefen, M.; Mandel, P.; Roos, F. C.; Chun, F. K. H.; Karakiewicz, P. I.
Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients 1-gen-2022 Sorce, G.; Flammia, R. S.; Hoeh, B.; Chierigo, F.; Horlemann, B.; Wurnschimmel, C.; Tian, Z.; Graefen, M.; Terrone, C.; Gallucci, M.; Chun, F. K. H.; Saad, F.; Shariat, S. F.; Montorsi, F.; Briganti, A.; Karakiewicz, P. I.
Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patterns+ 1-gen-2021 Wurnschimmel, C.; Wenzel, M.; Chierigo, F.; Flammia, R. S.; Mori, K.; Tian, Z.; Shariat, S. F.; Saad, F.; Briganti, A.; Suardi, N.; Terrone, C.; Gallucci, M.; Chun, F. K. H.; Tilki, D.; Graefen, M.; Karakiewicz, P. I.
Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy 1-gen-2022 Chierigo, F.; Flammia, R. S.; Sorce, G.; Hoeh, B.; Hohenhorst, L.; Panunzio, A.; Tian, Z.; Saad, F.; Graefen, M.; Gallucci, M.; Briganti, A.; Montorsi, F.; Chun, F. K. H.; Shariat, S. F.; Antonelli, A.; Guano, G.; Mantica, G.; Borghesi, M.; Suardi, N.; Terrone, C.; Karakiewicz, P. I.
Response to Re: External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients 1-gen-2022 Wurnschimmel, C.; Wenzel, M.; Chierigo, F.; Simone Flammia, R.; Tian, Z.; Saad, F.; Briganti, A.; Shariat, S. F.; Suardi, N.; Terrone, C.; Gallucci, M.; Chun, F. K. H.; Tilki, D.; Graefen, M.; Karakiewicz, P. I.
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer 1-gen-2022 Afferi, L.; Lonati, C.; Montorsi, F.; Briganti, A.; Necchi, A.; Mari, A.; Minervini, A.; Tellini, R.; Campi, R.; Schulz, G. B.; Black, P. C.; di Trapani, E.; de Cobelli, O.; Karnes, R. J.; Ahmed, M.; Mir, M. C.; Algarra, M. A.; Rink, M.; Zamboni, S.; Mondini, F.; Simeone, C.; Antonelli, A.; Tafuri, A.; Krajewski, W.; Malkiewicz, B.; Xylinas, E.; Soria, F.; Sanchez Salas, R.; Arora, A.; Cathelineau, X.; Hendricksen, K.; Ammiwala, M.; Borghesi, M.; Chierigo, F.; Teoh, J. Y. -C.; Mattei, A.; Albisinni, S.; Roghmann, F.; Roumiguie, M.; Bajeot, A. S.; Maier, E.; Aziz, A.; Hurle, R.; Contieri, R.; Pradere, B.; Carando, R.; Poyet, C.; Alvarez-Maestro, M.; D'Andrea, D.; Shariat, S. F.; Moschini, M.
Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer 1-gen-2022 Flammia, R. S.; Chierigo, F.; Wurnschimmel, C.; Wenzel, M.; Horlemann, B.; Tian, Z.; Borghesi, M.; Leonardo, C.; Tilki, D.; Shariat, S. F.; Anceschi, U.; Chun, F. K. H.; Terrone, C.; Saad, F.; Gallucci, M.; Karakiewicz, P. I.
Sexuality during COVID lockdown: a cross-sectional Italian study among hospital workers and their relatives 1-gen-2021 De Rose, A. F.; Chierigo, F.; Ambrosini, F.; Mantica, G.; Borghesi, M.; Suardi, N.; Terrone, C.